Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 19.04.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
19.04.23Mendus - Momentum gathering across the pipeline395Mendus recapped highlights of the positive clinical readouts from its ADVANCE II study in acute myeloid leukaemia (AML) in an investor update in conjunction with its annual filing. Management intends...
► Artikel lesen
19.04.23Context Therapeutics - R&D webinar highlights CTIM-76's potential492Context Therapeutics' April R&D webinar included takeaways from its poster presentation on CTIM-76 preclinical data at the AACR Annual Meeting in April 2023. The presentation highlighted the development...
► Artikel lesen
19.04.23Esker - Better outlook for FY23445Esker reported 17% y-o-y revenue growth for Q123, with 21% y-o-y growth in SaaS revenue (83% of group revenue) on an organic constant currency (cc) basis. Strong order momentum was maintained in the...
► Artikel lesen
19.04.23Basilea Pharmaceutica - Zevtera NDA submission pushed to Q323425Basilea has announced that there will be a minor delay in the timing of its new drug application (NDA) for Zevtera (ceftobiprole) to the FDA and it now anticipates submission in Q323 (previously H123)....
► Artikel lesen
19.04.23EML Payments - Shifting focus to solve current challenges344EML Payments has announced the appointment of a new interim CEO and a renewed focus to solve the immediate challenges facing the company. This includes strengthening support for the regulatory remediation...
► Artikel lesen
19.04.23Cantargia - Encouraging data for nadunolimab in CANFOUR410Cantargia has presented new data from the Phase I/IIa CANFOUR trial at the American Association for Cancer Research (AACR) 2023 meeting. This included an interim analysis of patients (n=73) with pancreatic...
► Artikel lesen